<DOC>
	<DOCNO>NCT03035578</DOCNO>
	<brief_summary>This research aim study baby 's body morphine morphine work baby 's body . One hundred newborn baby enrol study . With good understand drug doctor nurse information well administer drug case pain , stress discomfort .</brief_summary>
	<brief_title>Development Morphine Pharmacokinetic Pharmacodynamic Model Neonatal Population</brief_title>
	<detailed_description>Critically ill immature preterm infant experience multiple noxious stimulus receive care Neonatal Intensive Care Unit ( NICU ) . These noxious stimulus include , limited : venipuncture ; insertion intravenous arterial catheter ; suction nose , mouth oropharynx ; endotracheal intubation mechanical ventilation ; insertion chest drain ; reposition type patient manipulation . The delivery optimal dos analgesics noxious stimulus major challenge due lack knowledge drug disposition effect patient population . Morphine common analgesic use NICU . The Premature Infant Pain Profile ( PIPP ) use quantify pain NICU1 . This objective score , combine physiological behavioural variable define level discomfort , use guide use morphine newborn infant . Multidimensional pain assessment tool , PIPP , easily identify behaviour healthy infant undergo painful event , however , efficiency questionable applicable critically ill premature infant neurological impairment , pain processing modulation may alter . Pharmacokinetics/Pharmacodynamics ( PKPD ) model use quantitatively describe predict drug disposition blood target organ ( e.g. , brain ) relation dose patient characteristic . Although global effort describe morphine plasma level population use pharmacokinetic model approach2-5 , PKPD model development report . The study morphine pharmacokinetics determine optimal dose balance analgesia/sedation together design pharmacodynamic model morphine may provide good understand nociception/pain profile base physiological variable immature infant . Moreover , PKPD model may use achieve optimal therapeutic effect individualise model-based dose selection . Objective : This study compose four main objective : 1 . First : Define target morphine plasma brain concentration . To end , develop morphine PKPD model base population PK characteristic morphine effect capture functional readout central nervous system function ; 2 . Second : Develop opportunistic sample method fragile population base saliva sampling ; 3 . Third : Compare pharmacokinetic parameter calculate saliva plasma sample ; 4 . Fourth : Application morphine PKPD model prediction optimal morphine dose individual patient use Bayesian framework model refinement .</detailed_description>
	<mesh_term>Morphine</mesh_term>
	<criteria>Gestational age &gt; 24 complete week . Clinically prescribed commence continuous morphine infusion . Gestational age &lt; 24 complete week . Critically ill infant unlikely survive 72 hour . Prolonged fetal exposure morphine , narcotic , methadone , consequence maternal use drug . Any postnatal exposure morphine 72 hour prior commencement second morphine infusion . Neonates impaired cardiac , hepatic renal functioning define clinical sign impaired perfusion , abnormal liver function test , elevate serum creatinine . Neonates seizure . The attend neonatologist considers participation study contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>24 Weeks</minimum_age>
	<maximum_age>42 Weeks</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Morphine</keyword>
	<keyword>Neonatal</keyword>
</DOC>